Article Link: FDA Approves Keytruda (pembrolizumab) for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer KEN...
FDA Approves Fiasp (insulin aspart injection) for the Treatment of Children with Diabetes
Article Link: FDA Approves Fiasp (insulin aspart injection) for the Treatment of Children with Diabetes PLAINSBORO, N.J., Jan. 6, 2020 /P...
Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
Article Link: Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer ...
FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients
Article Link: FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients December 23, 2019 — Eisai Co., Ltd...
FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults
Article Link: FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) &...
FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine
Article Link: FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine DUBLIN, Dec. 23, 2019 /PRNewswire/ — Allergan p...
FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2 Based Regimens
Article Link: FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-Positive Unresectable or Metastatic Breast Cancer Following Two or More ...
FDA Approves Conjupri (levamlodipine maleate) for the Treatment of Hypertension
Article Link: FDA Approves Conjupri (levamlodipine maleate) for the Treatment of Hypertension Hong Kong, 20 December 2019 — The boa...
FDA Approves Ervebo (Ebola Zaire Vaccine, Live) for the Prevention of Disease Caused by Zaire Ebolavirus
Article Link: FDA Approves Ervebo (Ebola Zaire Vaccine, Live) for the Prevention of Disease Caused by Zaire Ebolavirus KENILWORTH, N.J.&#...
FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris
Article Link: FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris BRIDGEWATER, N.J., Dec. 19, 2019 /PRNews...
